Goodwin ProcterGoodwin Procter

Expertise

  1. Antitrust & Competition
  2. Appellate and Supreme Court Litigation
  3. Business & Commercial Litigation
  4. Complex Litigation & Dispute Resolution
  5. Data, Privacy & Cybersecurity
  6. Employment
  7. Environmental
  8. ERISA Litigation
  9. Financial Industry Litigation
  10. Government Investigations & Enforcement
  11. Intellectual Property
  12. Investment Management Litigation
  13. Litigation
  14. Products Litigation and Counseling
  15. Securities Litigation & SEC Enforcement
  16. Trade Secrets, Employee Mobility & Non-Competes
  17. White Collar Defense

  1. Antitrust & Competition
  2. Banking
  3. Data, Privacy & Cybersecurity
  4. Digital Currency & Blockchain
  5. Employment
  6. Environmental
  7. ERISA & Executive Compensation
  8. ESG & Impact
  9. Life Sciences Regulatory & Compliance
  10. Financial Restructuring
  11. Fintech
  12. Global Trade
  13. Healthcare Regulatory
  14. Insurtech
  15. Investment Management
  16. Late Stage Drug Development
  17. Private Investment Funds
  18. Risk Management & Insurance
  19. Tax
  20. Tax-Exempt Organizations
  21. Trusts & Estate Planning Advisory Services
  22. Trusts & Estate Planning
  23. Proptech
  24. Propsci

  1. Buyouts & Acquisitions
  2. Capital Markets
  3. Corporate Social Responsibility Law & Policy
  4. Data, Privacy & Cybersecurity
  5. Debt Finance
  6. Derivatives
  7. Digital Currency & Blockchain
  8. Employment
  9. Environmental
  10. ERISA & Executive Compensation
  11. ESG & Impact
  12. Financial Restructuring
  13. Growth Equity
  14. Intellectual Property
  15. Mergers & Acquisitions
  16. New Company Formation
  17. Private Investment Funds
  18. Public Company Advisory
  19. REITs & Real Estate M&A
  20. Search Funds
  21. Secondaries
  22. Shareholder Activism & Takeover Defense
  23. Special Purpose Acquisition Companies (SPACs)
  24. Tax
  25. Tax-Exempt Organizations
  26. Trusts & Estate Planning
  27. Trusts & Estate Planning Advisory Services
  28. Venture Capital

A

  1. Agribusiness
  2. Antitrust & Competition
  3. Antitrust Services for Life Sciences Companies
  4. Appellate and Supreme Court Litigation
  5. Artificial Intelligence & Machine Learning

B

  1. Banking
  2. Brokers, Exchanges, and Trading
  3. Business & Commercial Litigation
  4. Buyouts & Acquisitions

C

  1. Cannabis
  2. Capital Markets
  3. Class Actions
  4. Climate Tech
  5. Clinical Trials Services
  6. Complex Litigation & Dispute Resolution
  7. Consumer Financial Services
  8. Consumer Financial Services Enforcement & Government Investigations
  9. Consumer Financial Services Litigation
  10. Convergence
  11. Copyrights
  12. Corporate Social Responsibility Law & Policy
  13. Crowdfunding

D

  1. Data, Privacy & Cybersecurity
  2. Debt Capital Markets
  3. Debt Finance
  4. Derivatives
  5. Digital Currency & Blockchain
  6. Digital Health
  7. Direct Listings
  8. Distressed Real Estate

E

  1. Employment
  2. Environmental
  3. ERISA & Executive Compensation
  4. ERISA Litigation
  5. ESG & Impact

F

  1. Fair & Responsible Lending
  2. False Claims Act
  3. FDA Litigation
  4. Financial Industry Litigation
  5. Financial Restructuring
  6. Financial Services
  7. Fintech
  8. Food & Healthy Living
  9. Foreign Corrupt Practices Act

G

  1. Gaming & Gambling
  2. Global Trade
  3. Government Contracts & Disputes
  4. Government Investigations & Enforcement
  5. Growth Equity

H

  1. Hatch-Waxman, Biologics and Biosimilars Litigation
  2. Healthcare
  3. Healthcare Disputes & Investigations
  4. Healthcare Regulatory
  5. Healthcare Services
  6. Hedge Funds
  7. Higher Education
  8. Hospitality & Leisure

I

  1. Industrial Technology & Advanced Manufacturing
  2. Insurance
  3. Insurtech
  4. Intellectual Property
  5. Investment Management
  6. Investment Management Litigation
  7. ITC 337 Proceedings

L

  1. Late Stage Drug Development
  2. Leasing
  3. Life Sciences
  4. Life Sciences Asia
  5. Life Sciences Collaborations & Licensing
  6. Life Sciences Emerging Companies
  7. Life Sciences Europe
  8. Life Sciences IPOs & Capital Markets
  9. Life Sciences M&A
  10. Life Sciences Patent Prosecution & Counseling
  11. Life Sciences Regulatory & Compliance
  12. Life Sciences Securities Litigation & Healthcare Fraud
  13. Litigation

M

  1. Medtech
  2. Mergers & Acquisitions
  3. Metaverse
  4. Mining
  5. Mortgage Banking

N

  1. New Company Formation

O

  1. Operational Real Estate
  2. Opinions & Counseling

P

  1. Patent Litigation
  2. Patent Prosecution & Counseling
  3. Patent Trial & Appeal Board
  4. Pharmaceuticals
  5. Private Equity
  6. Private Equity Asia
  7. Private Equity France
  8. Private Equity Germany
  9. Private Equity UK
  10. Private Investment Funds
  11. Products Litigation and Counseling
  12. Proposition 65 & Food Labeling Litigation
  13. Propsci
  14. Proptech
  15. Public Company Advisory

R

  1. Real Estate
  2. Real Estate Acquisitions & Dispositions
  3. Real Estate Design & Construction
  4. Real Estate Development & Permitting
  5. Real Estate Dispute Resolution
  6. Real Estate Finance & Restructurings
  7. Real Estate Investment Funds
  8. Real Estate Joint Ventures
  9. Real Estate Tax
  10. REITs & Real Estate M&A
  11. Risk Management & Insurance

S

  1. Search Funds
  2. Secondaries
  3. Securities Litigation & SEC Enforcement
  4. Securitization & Derivatives
  5. Shareholder Activism & Takeover Defense
  6. Special Purpose Acquisition Companies (SPACs)
  7. State Attorneys General
  8. Strategic Technology Transactions and Licensing

T

  1. Tax
  2. Tax-Exempt Organizations
  3. Technology
  4. Technology Europe
  5. Technology M&A
  6. Trade Secrets, Employee Mobility & Non-Competes
  7. Trademarks
  8. Transportation
  9. Trusts & Estate Court Practice
  10. Trusts & Estate Planning
  11. Trusts & Estate Planning Advisory Services

V

  1. Venture Capital
  2. Venture Capital & Private Equity Funds

W

  1. White Collar Defense
  2. Women's Health & Wellness
SUBSCRIBE FOR UPDATES
Copyright © 2023 Goodwin Procter LLP